Ocular Therapeutix, Inc. (OCUL) announced on Monday that President and CEO Antony Mattessich will be stepping down.
Mattessich is being succeeded by Pravin Dugel, executive chairman, who will assume the roles of president and CEO, effective immediately.
In addition to these new responsibilities, Dugel will maintain his positions as a director and executive chairman of the company.
Dugel has previously served in leadership roles such as President of Iveric Bio, Inc.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.